BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Monica McNeal"”

10 results

IgA and Neutralizing Antibodies to Influenza A Virus in Human Milk: A Randomized Trial of Antenatal Influenza Immunization

Verified

Elizabeth P. Schlaudecker, Mark C. Steinhoff, Saad B. Omer, Monica McNeal et al.

Journal: PLoS ONEYear: 2013Citations: 209

BACKGROUND: Antenatal immunization of mothers with influenza vaccine increases serum antibodies and reduces the rates of influenza illness in mothers and their infants. We report the effect of antenatal immunization on the levels of specific anti-influenza IgA levels in human breast milk. (ClinicalT...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

Evidence for natural reassortants of human rotaviruses belonging to different genogroups

Verified

Robyn L. Ward, Osamu Nakagomi, D R Knowlton, Monica McNeal et al.

Journal: Journal of VirologyYear: 1990Citations: 79

Of 335 rotavirus isolates associated with diarrheal disease in Bangladesh that were culture adapted and subsequently characterized for electropherotype, subgroup, and serotype, 9 had properties that suggested they may be natural reassortants between human rotaviruses belonging to different "genogrou...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural Bangladesh

Verified

John D. Clemens, Robyn L. Ward, Malla Rao, David A. Sack et al.

Journal: The Journal of Infectious DiseasesYear: 1992Citations: 52

A case-control study was conducted among children and adult women in rural Bangladesh to evaluate whether serologic immunity to rotavirus was associated with a lower risk of rotavirus diarrhea of sufficient severity to cause patients to seek medical care. Acute-phase sera from 219 cases of rotavirus...

Health SciencesMedicineInfectious Diseases
Read Source

Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses

Verified

Robyn L. Ward, Monica McNeal, John D. Clemens, David A. Sack et al.

Journal: Journal of Clinical MicrobiologyYear: 1991Citations: 52

Rotaviruses collected in Bangladesh during 1985 to 1986 were culture adapted and used in a comparative serotyping study with three groups of monoclonal antibodies, all of which reacted with the major neutralization protein (VP7) of serotype 1, 2, 3, or 4. The goals were to determine which monoclonal...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial

Verified

Khalequ Zaman, Jessica A. Fleming, John C. Victor, Mohammad Yunus et al.

Journal: The Journal of Infectious DiseasesYear: 2016Citations: 46

BACKGROUND: The burden of rotavirus morbidity and mortality is high in children aged <5 years in developing countries, and evaluations indicate waning protection from rotavirus immunization in the second year. An additional dose of rotavirus vaccine may enhance the immune response and lengthen the p...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh

Verified

Benjamin Lee, Marya P. Carmolli, Dorothy M. Dickson, E. Ross Colgate et al.

Journal: Clinical Infectious DiseasesYear: 2018Citations: 38

Background: Rotavirus (RV)-specific immunoglobulin A (IgA) responses following oral RV vaccination are impaired in low-income countries, where the utility of RV-IgA as a correlate of protection (CoP) remains unclear. In a monovalent oral RV vaccine (Rotarix) efficacy trial among infants in Dhaka, Ba...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986

Verified

Robyn L. Ward, John D. Clemens, David A. Sack, D R Knowlton et al.

Journal: Journal of Clinical MicrobiologyYear: 1991Citations: 33

Group A rotaviruses collected between 1985 and 1986 during comprehensive surveillance of treated diarrheal episodes occurring in a rural Bangladesh population were culture adapted and characterized by electropherotype, serotype, and subgroup. Of 454 episodes of rotavirus-associated diarrhea, rotavir...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

INCIDENCE OF INFLUENZA VIRUS INFECTION IN EARLY INFANCY

Verified

Emily Henkle, Mark C. Steinhoff, Saad B. Omer, Eliza Roy et al.

Journal: The Pediatric Infectious Disease JournalYear: 2010Citations: 23

We evaluated infant sera from an immunization trial in Bangladesh to assess influenza hemagglutination inhibition antibody titer increases in 131 unimmunized infants from birth to 6 months. We detected 31 serologically defined infections. Combined with 10 additional rapid test-proven influenza cases...

Health SciencesMedicineEpidemiology
Read Source

The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial

Verified

Benjamin Lee, Dorothy M. Dickson, Masud Alam, Sajia Afreen et al.

Journal: VaccineYear: 2019Citations: 14

Background: Oral, live-attenuated rotavirus vaccines suffer from impaired immunogenicity and efficacy in low-income countries. Increasing the inoculum of vaccine might improve vaccine response, but this approach has been inadequately explored in low-income countries. Methods: We performed a double-b...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source

Immunogenicity of a third scheduled dose of rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a phase IV, double-blind, randomised, placebo-controlled clinical trial

Verified

Bianca F. Middleton, Margie Danchin, Mark Jones, Amanda Leach et al.

Journal: medRxivYear: 2021

Background The oral rotavirus vaccine, Rotarix (GlaxoSmithKline), is licensed for use in infants as two doses in the first six months of life. For infants living in settings with high child-mortality, and also for rural and remote Australian Aboriginal infants, clinical protection conferred by two d...

Health SciencesMedicineInfectious DiseasesOpen Access
Read Source
PreviousPage 1 of 1Next